The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Murali Ramachandran since 2024.
This trader's CIK number is 1870016.
At the time of last reporting, Murali Ramachandran was the VP of Research and Development of Kairos Pharma, Ltd.. (stock ticker symbol KAPA).
Also see all insider trading activities at Kairos Pharma, Ltd..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | KAPA | 200 | $318 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-11-25 | KAPA | Buy | 200 | 1.59 | 318 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Murali Ramachandran (VP of Research and Development of Kairos Pharma, Ltd. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.